2022 ISPE Biotechnology Conference Program Committee
Thank you to the 2022 ISPE Biotechnology Conference Program Committee for putting in so much time to create such a highly technical and informative experience—and today was only day 1 of 3!
As ISPE CEO And President Thomas Hartman, noted during welcoming remarks today, this is a group of subject matter experts unparalleled in the industry when it comes to biotech conference planning.
Integrated Drug substance Manufacturing
Narendra Bam, PhD, Senior Vice President, Medicine Development and Supply, GSK, explored biopharmaceutical manufacturing innovations on the horizon, highlighting examples from GSK’s manufacturing technology development portfolio of projects during his keynote presentation at the 2022 #ISPEBio Conference.
Watch this clip to hear Dr. Bam speak about how continuous manufacturing offers several key benefits to biopharmaceuticals.
What makes advanced therapy medicinal products (ATMPs) different from traditional products?
Jasna Curak, Global Quality and External Collaboration Manager, Roche, explored this during her 2022 #ISPEBio Conference presentation "ATMPs - GMP Challenges."
2022 ISPE Biotechnology Conference Gallery
What Are Some Skills That You Need to Develop as You Move through Your Career to Ensure You’re Prepared for the Next Step?
Prudence Edwards, Double Degree Engineering Student (University of Queensland/Centrale Marseille), posed this question as she led the panel Q&A during the ISPE Think Tank session "Expanding Your Footprint: Opportunities in Biotech," presented by Women in Pharma® during the 2022 #ISPEBio Conference.
Watch this clip to hear what panelist Lindsey Daniel, PE, Product Operations Program Manager, Takeda, had to say.
How Can a New Company Platform in Startup Made with 300 People Embark to Save the World?
During the closing session of the 2022 #ISPEBio Conference, keynote Juan Andres, Chief Technical Operations and Quality Officer, Moderna, discussed his company’s journey from start-up to scale-up, overcoming challenges, and moving into the future.
It goes without saying that reflecting on the last few years, immense progress has been made in the biopharmaceutical industry. We have seen an industry prioritising collaboration and innovation, combined with a healthy competitive spirit, brought new technology to reality, and achieved milestones in twelve months that would previously have taken a decade.
mRNA is back at the 2022 ISPE Biotechnology Conference. Last year we learned from major key players about their journey to develop first time mRNA vaccines against COVID-19 and build manufacturing capacity for billions of doses in less than one year. In 2022 we are revising the relevance of mRNA technology and widening the view beyond the COVID vaccine.
Think Tanks are meant to mobilize expertise and ideas to influence processes and procedures and help address global issues – a concept perfectly in line with the goals and mission of ISPE, the pharmaceutical industry’s largest nonprofit association committed to connecting over 20,000 peers across 90 countries. Through online and in-person forums, ISPE members can gain industry knowledge, learn...
Digital transformation has been growing in importance and urgency as the biopharma and biotech industry, manufacturers, and service providers seek to accelerate build-out of facilities and manufacturing processes in support of advanced biotherapeutics.